Mesenchymal stromal cells
- PMID: 19796238
- DOI: 10.1111/j.1749-6632.2009.04607.x
Mesenchymal stromal cells
Abstract
Mesenchymal stromal cells (MSCs) are multipotent cells that can be isolated from several human tissues and expanded ex vivo for clinical use. MSCs are identified by their adherent properties, immunephenotype, and differentiation potential. MSCs display immunological properties that have been demonstrated both in vitro and in vivo, in animal models and in humans, although the exact mechanisms underlying these effects remain largely unknown. MSCs preferentially home to damaged tissue and secrete paracrine factors with anti-inflammatory properties. The immunomodulatory and reparative and anti-inflammatory properties of MSCs have been tested in a variety of animal models and have been applied in specific clinical settings. Potential clinical applications of MSCs include prevention and treatment of therapy-resistant acute graft-versus-host disease, prevention and treatment of rejection after either hematopoieitc stem cell and solid organ transplantation, tissue repair, and treatment of inborn errors and autoimmune diseases. This review focuses on recent advances that have broadened our understanding of the biological and functional properties of MSCs, which are increasingly attracting the attention of researchers involved in the optimization of approaches for reparative and regenerative cell therapy, as well as in the perspective of modulating immune response against alloantigens or, even, autoantigens.
Similar articles
-
Multipotent mesenchymal stromal cell therapy in renal disease and kidney transplantation.Nephrol Dial Transplant. 2010 Jan;25(1):17-24. doi: 10.1093/ndt/gfp552. Epub 2009 Oct 26. Nephrol Dial Transplant. 2010. PMID: 19861311 Review.
-
Mesenchymal stem cell therapy for degenerative inflammatory disorders.Curr Opin Organ Transplant. 2008 Dec;13(6):639-44. doi: 10.1097/MOT.0b013e328317a462. Curr Opin Organ Transplant. 2008. PMID: 19060556 Review.
-
Immunomodulation by multipotent mesenchymal stromal cells.Transplantation. 2007 Jul 15;84(1 Suppl):S35-7. doi: 10.1097/01.tp.0000269200.67707.c8. Transplantation. 2007. PMID: 17632411
-
Immunomodulation by mesenchymal stem cells and clinical experience.J Intern Med. 2007 Nov;262(5):509-25. doi: 10.1111/j.1365-2796.2007.01844.x. J Intern Med. 2007. PMID: 17949362 Review.
-
Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell-therapy approaches: further insights in the search for a fetal calf serum substitute.J Cell Physiol. 2007 Apr;211(1):121-30. doi: 10.1002/jcp.20911. J Cell Physiol. 2007. PMID: 17187344
Cited by
-
Comparison of Adipose-Derived and Bone Marrow Mesenchymal Stromal Cells in a Murine Model of Crohn's Disease.Dig Dis Sci. 2017 Jan;62(1):115-123. doi: 10.1007/s10620-016-4166-6. Epub 2016 Apr 23. Dig Dis Sci. 2017. PMID: 27107864
-
The mood stabilizers valproic acid and lithium enhance mesenchymal stem cell migration via distinct mechanisms.Neuropsychopharmacology. 2010 Oct;35(11):2225-37. doi: 10.1038/npp.2010.97. Epub 2010 Jul 7. Neuropsychopharmacology. 2010. PMID: 20613717 Free PMC article.
-
miR-335 correlates with senescence/aging in human mesenchymal stem cells and inhibits their therapeutic actions through inhibition of AP-1 activity.Stem Cells. 2014 Aug;32(8):2229-44. doi: 10.1002/stem.1699. Stem Cells. 2014. PMID: 24648336 Free PMC article.
-
Treatment of acute respiratory distress syndrome with allogeneic adipose-derived mesenchymal stem cells: a randomized, placebo-controlled pilot study.Respir Res. 2014 Apr 4;15(1):39. doi: 10.1186/1465-9921-15-39. Respir Res. 2014. PMID: 24708472 Free PMC article. Clinical Trial.
-
Mesenchymal stromal cell application as an emerging translational medicine for acute respiratory distress syndrome.Ann Transl Med. 2020 Mar;8(6):267. doi: 10.21037/atm.2020.02.82. Ann Transl Med. 2020. PMID: 32355711 Free PMC article. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources